194 related articles for article (PubMed ID: 33560669)
1. The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives.
Cupido AJ; Tromp TR; Hovingh GK
Curr Opin Lipidol; 2021 Apr; 32(2):112-116. PubMed ID: 33560669
[TBL] [Abstract][Full Text] [Related]
2. Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia.
Trinder M; Li X; DeCastro ML; Cermakova L; Sadananda S; Jackson LM; Azizi H; Mancini GBJ; Francis GA; Frohlich J; Brunham LR
J Am Coll Cardiol; 2019 Jul; 74(4):512-522. PubMed ID: 31345425
[TBL] [Abstract][Full Text] [Related]
3. Polygenic Risk Score for Low-Density Lipoprotein Cholesterol Is Associated With Risk of Ischemic Heart Disease and Enriches for Individuals With Familial Hypercholesterolemia.
Wu H; Forgetta V; Zhou S; Bhatnagar SR; Paré G; Richards JB
Circ Genom Precis Med; 2021 Feb; 14(1):e003106. PubMed ID: 33440130
[TBL] [Abstract][Full Text] [Related]
4. Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.
Trinder M; Paquette M; Cermakova L; Ban MR; Hegele RA; Baass A; Brunham LR
Circ Genom Precis Med; 2020 Oct; 13(5):515-523. PubMed ID: 33079599
[TBL] [Abstract][Full Text] [Related]
5. Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia.
Nomura A; Sato T; Tada H; Kannon T; Hosomichi K; Tsujiguchi H; Nakamura H; Takamura M; Tajima A; Kawashiri MA
J Hum Genet; 2021 Nov; 66(11):1079-1087. PubMed ID: 33967275
[TBL] [Abstract][Full Text] [Related]
6. Polygenic Hyperlipidemias and Coronary Artery Disease Risk.
Ripatti P; Rämö JT; Mars NJ; Fu Y; Lin J; Söderlund S; Benner C; Surakka I; Kiiskinen T; Havulinna AS; Palta P; Freimer NB; Widén E; Salomaa V; Tukiainen T; Pirinen M; Palotie A; Taskinen MR; Ripatti S;
Circ Genom Precis Med; 2020 Apr; 13(2):e002725. PubMed ID: 32154731
[TBL] [Abstract][Full Text] [Related]
7. Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
Sharifi M; Higginson E; Bos S; Gallivan A; Harvey D; Li KW; Abeysekera A; Haddon A; Ashby H; Shipman KE; Cooper JA; Futema M; Roeters van Lennep JE; Sijbrands EJG; Labib M; Nair D; Humphries SE
Atherosclerosis; 2017 Aug; 263():405-411. PubMed ID: 28549500
[TBL] [Abstract][Full Text] [Related]
8. Polygenic contribution for familial hypercholesterolemia (FH).
Medeiros AM; Bourbon M
Curr Opin Lipidol; 2021 Dec; 32(6):392-395. PubMed ID: 34751168
[TBL] [Abstract][Full Text] [Related]
9. A new 165-SNP low-density lipoprotein cholesterol polygenic risk score based on next generation sequencing outperforms previously published scores in routine diagnostics of familial hypercholesterolemia.
Vanhoye X; Bardel C; Rimbert A; Moulin P; Rollat-Farnier PA; Muntaner M; Marmontel O; Dumont S; Charrière S; Cornélis F; Ducluzeau PH; Fonteille A; Nobecourt E; Peretti N; Schillo F; Wargny M; Cariou B; Meirhaeghe A; Di Filippo M
Transl Res; 2023 May; 255():119-127. PubMed ID: 36528340
[TBL] [Abstract][Full Text] [Related]
10. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C;
Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832
[TBL] [Abstract][Full Text] [Related]
11. Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations.
Olmastroni E; Gazzotti M; Arca M; Averna M; Pirillo A; Catapano AL; Casula M;
J Am Heart Assoc; 2022 Apr; 11(7):e023668. PubMed ID: 35322671
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia.
Futema M; Bourbon M; Williams M; Humphries SE
Atherosclerosis; 2018 Oct; 277():457-463. PubMed ID: 30270085
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants associated with low-density lipoprotein cholesterol and systolic blood pressure and the risk of recurrent cardiovascular disease in patients with established vascular disease.
Groenland EH; Heidemann BE; van der Laan SW; van Setten J; Koopal C; Bots ML; Asselbergs FW; Visseren FLJ; Spiering W;
Atherosclerosis; 2022 Jun; 350():102-108. PubMed ID: 35317921
[TBL] [Abstract][Full Text] [Related]
14. Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemia.
Tromp TR; Cupido AJ; Reeskamp LF; Stroes ESG; Hovingh GK; Defesche JC; Schmidt AF; Zuurbier L
Atherosclerosis; 2022 Jan; 340():61-67. PubMed ID: 34774301
[TBL] [Abstract][Full Text] [Related]
15. Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort.
Lima IR; Tada MT; Oliveira TGM; Jannes CE; Bensenor I; Lotufo PA; Santos RD; Krieger JE; Pereira AC
Atheroscler Plus; 2022 Aug; 49():47-55. PubMed ID: 36644206
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of polygenic cause in Korean patients with familial hypercholesterolemia - A study supported by Korean Society of Lipidology and Atherosclerosis.
Kwon M; Han SM; Kim DI; Rhee MY; Lee BK; Ahn YK; Cho BR; Woo J; Hur SH; Jeong JO; Jang Y; Lee SH; Lee JH
Atherosclerosis; 2015 Sep; 242(1):8-12. PubMed ID: 26160041
[TBL] [Abstract][Full Text] [Related]
17. Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
Brandts J; Dharmayat KI; Ray KK; Vallejo-Vaz AJ
Curr Opin Lipidol; 2020 Jun; 31(3):111-118. PubMed ID: 32332432
[TBL] [Abstract][Full Text] [Related]
18. Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia.
Ravnskov U; de Lorgeril M; Kendrick M; Diamond DM
Med Hypotheses; 2018 Dec; 121():60-63. PubMed ID: 30396495
[TBL] [Abstract][Full Text] [Related]
19. Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels.
Bianconi V; Banach M; Pirro M;
Trends Cardiovasc Med; 2021 May; 31(4):205-215. PubMed ID: 32205033
[TBL] [Abstract][Full Text] [Related]
20. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
